Category:
BIOTECHNOLOGY
Medical Device News Magazine reports breaking biotechnology news in addition to medical device news.
Study Published in JNCI Cancer Spectrum Demonstrates Real-World Utility of Veracyte’s Decipher Prostate Genomic Classifier in Prostate Cancer Treatment
The study utilized data from the first linkage of prostate cancer cases reported by central cancer registries participating in the Surveillance, Epidemiology, and End Results (SEER) Program, with Decipher test results. SEER is a population-based cancer registry supported by the National Cancer Institute (NCI). The findings appear online in JNCI Cancer Spectrum.
Gyros Protein Technologies introduces PurePep EasyClean Auto Kit for Automated Parallel Peptide Purification
Based on Gyros Protein Technologies’ orthogonal PurePep EasyClean technology, the PEC Auto Kit utilizes a simple catch-and-release methodology for purification of chemically synthesized peptides.
The phase 1/2 Clinical trial of Bevacizumab for Treatment of Ophthalmic Diseases Completed
This single-arm, open-label, multicentre, phase I/II study aimed to evaluate the safety and preliminary efficacy of EB12-20145P (HLX04-O) via intravitreal injection (IVT) in patients with active wet age-related macular degeneration (wAMD).
General Biologicals Corporation Debuts Award-Winning Brand at Scientific Clinical Lab Expo
General Biologicals introduces two CellBio CTC cancer detection devices at AACC and introduces GB RealQuant AIO Sample-To-Results automated molecular system at AACC
BD CEO Tom Polen Addresses FDA 510(k) Clearance of BD Alaris™ Infusion System
"Now that we have FDA clearance, we are eager to return to full commercial operations with an enhanced and updated Alaris System that we believe is the most comprehensive and innovative infusion solution on the market. The updated Alaris System addresses all open recalls, with the latest hardware, a new version of software, and important cybersecurity updates. With this release, we've improved the fundamental capabilities and features of the Alaris System. This further embodies and demonstrates BD's commitment to quality and developing smart, connected devices to support the safe and efficient care of patients.
CHMP Recommends Evrysdi ® for Babies Under Two Months Old with Spinal Muscular Atrophy
"The CHMP opinion represents another important milestone in the development of Evrysdi," said Matthew B. Klein, M.D., Chief Executive Officer, PTC Therapeutics. "Presymptomatic babies are an important patient group that deserve access to oral, at-home administered treatments early in the disease."
SunHo Announces First Patient Dosed in Phase I/II Clinical Trial of a Potential First-in-class Immunocytokine IBB0979
Dr. Liusong Yin, the Executive Director, Chief Executive Officer and Chief Science Officer of SunHo, "We focus on innovative immunocytokines to build the next leading global biopharma of immunotherapy, and to bring perceivable benefits and affordable medicine to patients worldwide, by innovation and collaboration."
Lytix Biopharma Announces Presentation of Interim Data from ATLAS-IT-05 Study at ESMO 2023
In ATLAS-IT-05, a Phase II study, LTX-315 is given to patients with advanced melanoma in combination with the immune checkpoint inhibitor pembrolizumab (Keytruda), a market leading approved immunotherapeutic antibody. In the abstract interim efficacy and safety data from the first patients enrolled in the Phase II study are presented.
PrecisionLife Identifies First Detailed Genetic Risk Factors for Long COVID and Common Mechanisms with ME/CFS and other Complex Diseases
This analysis opens the door for new precision diagnostic and therapeutic approaches to address the massive unmet medical need affecting the lives of millions of patients reports PrecisionLife.
